Sai Life Sciences Ltd share price logo

Sai Life Sciences Ltd

NSE: SAILIFE

BSE: 544306

Small Cap

Pharma Sector

₹1543.00

+1.50

(+0.10%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Sai Life Sciences shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+53%

Searches for Sai Life Sciences on INDmoney have increased by 53% over the last 30 days.

Investment activity on INDmoney

+43.77%

Investment activity in Sai Life Sciences among INDmoney users has increased by 43.77% over the last 30 days.

Among the most traded stocks

198th

Sai Life Sciences was the 198th most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

19 days

INDmoney investors hold Sai Life Sciences shares for an average of 19 days.

Sai Life Sciences Stock Performance

as on September 16, 2026 at 6:36 pm IST

  • Day's Low

    Day's High

    ₹1,494.40
    ₹1,556.20
    downward going graph

    3.15%

    Downside

    0.86%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹783.85
    ₹1,697.00
    downward going graph

    49.20%

    Downside

    9.98%

    Upside

    downward going graph

Sai Life Sciences share price movements today

Previous Close
₹1,541.50
Open
₹1,542.00
Volume
5.21L
Upper Circuit
₹1,849.80
Lower Circuit
₹1,233.20
Day's Low - High
₹1,494.40 - ₹1,556.20
52 Week Low - High
₹783.85 - ₹1,697.00

Sai Life Sciences Historical Returns

1 Month Return
+ 8.83 %
3 Month Return
+ 27.79 %
1 Year Return
+ 74.9 %
3 Year Return
+ 101.6 %
5 Year Return
+ 101.6 %

Sai Life Sciences Fundamentals

as on September 16, 2026 at 1:06 pm IST

Market Cap

₹32,740.57 Cr

Return on Equity (ROE)

14.61

PE Ratio (TTM)

92.31

Return on capital employed (ROCE)

18.71

Industry PE ratio

51.81

Beta (LTM)

0.78

P/B Ratio

8.2

Dividend Yield

0

PEG Ratio

18.76

Quarterly Earnings Growth YOY

21.22

EPS (TTM)

16.48

Book Value

117.28

Sai Life Sciences Stock Valuation

as on September 16, 2026 at 1:06 pm IST

Sai Life Sciences in the last 5 years

  • Overview

  • Trends

Lowest (18.46x)

January 27, 2025

Industry (51.81x)

September 11, 2026

Today (92.31x)

September 11, 2026

Highest (97.58x)

September 9, 2026

LowHigh

Today’s Price to Earnings Ratio: 92.31x

Sai Life Sciences Technical Analysis

Track how Sai Life Sciences technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish2
Bullish12
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
0.66
Bearish
CCI (20)
-375.32
Bullish
RSI (14)
55.65
Neutral
Momentum (10)
1
Bullish
ADI (14)
32.46
Bearish
Ultimate Oscillator (7,14,28)
71.46
Bullish

Moving Averages

Name

Value

Action

SMA (20)
1541.69
Bullish
EMA (20)
1541.76
Bullish
VWMA (20)
1542.15
Bullish
SMA (50)
1540.39
Bullish
EMA (50)
1540.24
Bullish
SMA (200)
1529.7
Bullish
EMA (200)
1535.9
Bullish
KAMA (200)
1537.91
Bullish
DEMA (200)
1534.73
Bullish

Sai Life Sciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sai Life Sciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Sai Life Sciences Ltd image
Sai Life Sciences Ltd
BUY32,740.5720.32%0.563482,192
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Market expectation of Sai Life Sciences Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Sai Life Sciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
383.63
439.21
279.72
395.56
439.78
579.51
496.42
537.47
556.46
602.14
554.29
Other Income
11.29
3.34
8.11
9.95
9.12
9.6
9.9
15.33
8.38
15.81
3.54
Total Income
394.92
442.55
287.84
405.52
448.89
589.11
506.32
552.8
564.84
617.95
557.83
Expenses
287.29
314.55
253.61
293.34
320.03
421.93
375.49
391.65
376.9
425.59
406.28
Operating Profit
96.34
124.66
26.11
102.22
119.75
157.58
120.93
145.82
179.56
176.55
148.01
Operating Profit Margin %
25.11%
28.38%
9.33%
25.84%
27.23%
27.19%
24.36%
27.13%
32.27%
29.32%
26.7%
Profit Before Interest, Tax and Depreciation
107.63
128
34.23
112.17
128.87
167.17
130.84
161.15
187.94
192.36
151.55
Interest
23.28
20.89
21.22
20.93
23.13
10.89
12.36
9.35
9.7
7.83
7.64
Depreciation
31.41
31.05
31.07
35.92
34.09
37.49
37.72
39.75
44.08
45.31
45.94
Profit Before Tax
52.94
76.06
-18.06
55.32
71.65
118.79
80.76
112.05
134.16
139.22
97.97
Tax Paid
13.33
19.92
-4.57
13.82
17.8
30.53
20.3
28.2
33.8
34.99
24.69
Profit After Tax
39.61
56.13
-13.5
41.51
53.85
88.27
60.46
83.84
100.38
104.24
73.29
Total Net profit including share of profit / Loss from associate company
39.61
56.13
-13.5
41.51
53.85
88.27
60.46
83.84
100.38
104.24
73.29
EPS
2.19
31
-0.74
2.22
2.89
4.24
2.9
4.01
4.77
4.93
3.46
Actual EPS
2.19
31
-0.74
2.22
2.89
4.24
2.9
4.01
4.77
4.93
3.46
Adjusted EPS
2.19
31
-0.74
2.22
2.89
4.24
2.9
4.01
4.77
4.93
3.46
Diluted EPS
2.17
30.7
-0.74
2.21
2.84
4.14
2.9
3.93
4.71
4.87
3.42

Sai Life Sciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
869.59
1,217.14
1,465.18
1,694.57
2,192.49
Other Income
28.15
27.97
29.09
36.78
49.13
Total Income
897.74
1,245.11
1,494.27
1,731.35
2,241.62
Expenses
748.31
1,052.21
1,179.69
1,288.91
1,569.33
Operating Profit
121.28
164.93
285.49
405.66
623.16
Operating Profit Margin %
13.95%
13.55%
19.48%
23.94%
28.42%
Profit Before Interest, Tax and Depreciation
149.43
192.9
314.58
442.44
672.29
Interest
49.57
77.06
85.91
76.16
39.24
Depreciation
90.16
99.43
119.44
138.57
166.86
Profit Before Tax
9.7
16.41
109.23
227.71
466.19
Tax Paid
3.47
6.42
26.43
57.57
117.28
Profit After Tax
6.23
9.99
82.81
170.13
348.91
Total Net profit including share of profit / Loss from associate company
6.23
9.99
82.81
170.13
348.91
EPS
3.47
7.51
46.44
8.83
16.63
Actual EPS
3.47
7.51
46.44
8.83
16.63
Adjusted EPS
3.47
7.51
46.44
8.83
16.63
Diluted EPS
3.47
7.51
46.44
8.61
16.64

Sai Life Sciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
129.14
115.5
-36.38
104.87
219.4
263.09
314.05
509.13
Cash Flow from Investing Activities
-157.67
-261.69
-259.89
-101.64
-99
-191.35
-536.39
-394.59
Cash Flow from Financing Activities
267.54
-4.07
295.51
71.92
-200.65
-95.31
301.43
-123.69
Net Cash Flow
239
-150.26
-0.78
75.15
-80.25
-23.56
79.08
-9.14

Sai Life Sciences Stock Shareholding Pattern

Numbers in percentages

Jul 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
39.64%
35.24%
35.24%
35.17%
35.15%
34.94%
34.7%
34.61%
34.53%
DII
0%
5.61%
11.95%
13.26%
21.64%
29.91%
31.41%
31.54%
32.71%
FII
0%
7.64%
11.72%
12.36%
14.58%
22.5%
21.4%
21.17%
19.65%
Public
0%
51.52%
41.09%
39.21%
28.64%
12.65%
12.49%
12.68%
13.11%
Total Outstanding Shares
18,39,20,340
20,79,89,529
20,79,89,529
20,84,14,389
20,85,45,302
20,97,49,267
21,12,31,216
21,17,79,234
21,22,86,016
Total Shareholders
70
5,72,970
1,81,122
1,40,677
1,26,380
1,19,705
1,14,820
1,17,527
1,25,096

Mutual Funds Buying / Exiting Sai Life Sciences

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Sai Life Sciences

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Nippon India Multi Cap Fund - Direct Plan - Growth

Nippon India Multi Cap Fund - Direct Plan - Growth

₹612.40 Cr

₹52.60 Cr (+9.40%)

1.03%

Mutual Funds Exiting Sai Life Sciences

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Sai Life Sciences Corporate Actions

View detailed summary of the earnings and dividend history of Sai Life Sciences.

  • Sai Life Sciences Ltd Earnings Results

    Sai Life Sciences Ltd’s net profit jumped 21.22% since last year same period to ₹73.29Cr in the Q1 2026-2027. On a quarterly growth basis, Sai Life Sciences Ltd has generated -29.69% fall in its net profits since last 3-months.

    Read More about Earnings Results

Indices Featuring Sai Life Sciences Stock

Check stock indices that include Sai Life Sciences.

Nifty Small 100

₹19,408.30

-14.15 (▲0.07%)

Nifty Smallcap 50

₹9,717.25

+3.55 (▲0.04%)

S&P BSE 400 MidSmallCap

₹12,413.60

+6.76 (▲0.05%)

BSE Healthcare

₹50,335.62

-143.19 (▲0.28%)

Nifty Smallcap 250

₹17,876.00

-16.80 (▲0.09%)

Nifty 500

₹22,569.70

+92.25 (▲0.41%)

S&P BSE 250 SmallCap

₹7,047.93

-4.69 (▲0.07%)

NIFTY PHARMA

₹26,095.60

-92.80 (▲0.35%)

Nifty MidSmallcap 400

₹20,762.60

+11.90 (▲0.06%)

BSE 500

₹35,304.92

+135.30 (▲0.38%)

Insights on Sai Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 12.68% to 13.11% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 27.80% to 29.47% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 34.61% to 34.53% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 21.17% to 19.65% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SAILIFE stock has moved down by -8.0%

About Sai Life Sciences Ltd

Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited as a Public Limited Company dated January 25 1999 issued by the Registrar of Companies Andhra Pradesh at Hyderabad. The Company received the Certificate of Commencement of Business from Registrar of Companies Andhra Pradesh on February 17 1999. Subsequently the Company name was changed from Sai Dru Syn Laboratories Limited to Sai Life Sciences Limited dated December 16 2003.Thereafter the name of the Company was changed from Sai Life Sciences Limited to Sai Advantium Pharma Limited dated August 30 2006 issued by the Registrar of Companies Andhra Pradesh. Subsequently the Company name was changed from Sai Advantium Pharma Limited to Sai Life Sciences Limited and a fresh Certificate of Incorporation dated May 28 2012 was issued by the Registrar of Companies Andhra Pradesh at Hyderabad.The Company is an innovatorfocused contract research development and manufacturing organization CRDMO. The Company provide endtoend services across the drug discovery development and manufacturing value chain for small molecule NCE to global pharmaceutical innovators companies and biotechnology firms. It possess both a discovery / contract research and b CMC / CDMO capabilities.Through the Scheme of Amalgamation Prasad Drugs Limited was merged into the Company in 2004. The Company acquired Merrifield Pharma Private Limited in 2006. Later the Company opened new areas of biology facility in Watertown Greater Boston MA U.S.A. for innovative and creative smallmolecule drugs in 2019. It launched Sai Nxt an initiative to transform the organization into a new generation CDMO in 2020. It further added cellular analysis platforms at its discovery biology facility in Cambridge Massachusetts USA.In 2021 the Company opened a new discovery biology facility at Unit II Plant in Hyderabad. In 2022 it opened the first set of new disconvery chemistry labs at Unit III Plant Hyderabad. In 2023 the Company opened high potency API manufacturing block at Unit IV Bidar Facility and has started API developability formulations DF capabilities at Unit II Hyderabad in 2024.The Company is proposing to raise money from public through IPO by issue and allotment of 61573120 Equity Shares through Offer for Sale and a Fresh Issue aggregating to Rs 800 Crores Equity Shares..

Revenue: ₹554.29Cr as on June 2026 (Q1 FY27)
Net Profit: ₹73.29Cr as on June 2026 (Q1 FY27)
Listing date: 18 Dec, 2024
Chairperson Name: Ranga Raju Kanumuri
OrganisationSai Life Sciences Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEORanga Raju Kanumuri
E-voting on sharesClick here to vote

FAQs

What is Sai Life Sciences share price today?

Sai Life Sciences share price today stands at ₹1543 as on . Sai Life Sciences share today touched a day high of ₹1556.2 and a low of ₹1494.4.

What is the 52 week high and 52 week low range for Sai Life Sciences share?

Sai Life Sciences touched a 52 week high of ₹1697 and a 52 week low of ₹783.85. Sai Life Sciences share price today i.e. is trending at ₹1543, which is -9.07% down from its 52 week high and 96.85% up from its 52 week low.

What is Sai Life Sciences's market capitalisation today?

Sai Life Sciences market capitalisation is ₹32,740.57 Cr as on .

How to buy Sai Life Sciences shares?

To buy Sai Life Sciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SAILIFE or Sai Life Sciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sai Life Sciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sai Life Sciences trading volume today?

Sai Life Sciences trading volume is 5.21L as on . This means that 5.21L shares of Sai Life Sciences were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Sai Life Sciences shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Sai Life Sciences have both increased over the past 30 days, and the average INDmoney investor holds the stock for 19 days. This reflects platform activity only and is not investment advice.